Pages that link to "Q34323402"
Jump to navigation
Jump to search
The following pages link to Safety and rational use of the triptans (Q34323402):
Displaying 13 items.
- Almotriptan: a review of its use in migraine (Q28216921) (← links)
- Rizatriptan: an update of its use in the management of migraine (Q34136456) (← links)
- Pharmacoeconomic evidence and considerations for triptan treatment of migraine (Q34544706) (← links)
- Safety profile of the triptans (Q35194407) (← links)
- Safety and efficacy of eletriptan in the treatment of acute migraine (Q36408742) (← links)
- Current and prospective pharmacological targets in relation to antimigraine action (Q37216396) (← links)
- The pharmacological management of migraine, part 1: overview and abortive therapy (Q37340160) (← links)
- Sumatriptan therapy for headache and acute myocardial infarction (Q37803238) (← links)
- From the field of play to the field of combat: a review of the pharmacological management of concussion (Q37979980) (← links)
- Headache, cerebral aneurysms, and the use of triptans and ergot derivatives (Q38436592) (← links)
- A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine. (Q40481850) (← links)
- In the pipeline. Triptans--new developments (Q44171192) (← links)
- Current literature in. Pharmacoepidemiology and drug safety (Q78073575) (← links)